--- title: "Zhongheng Group's wholly-owned subsidiary has received the approval notice for drug clinical trials" type: "News" locale: "en" url: "https://longbridge.com/en/news/236023083.md" description: "Zhongheng Group's wholly-owned subsidiary, Guangxi Zhongheng Innovative Pharmaceutical Research Co., Ltd., has received the clinical trial notification for Sanqi Granules approved by the National Medical Products Administration. This drug will be used for Phase II and III clinical trials for chronic glomerulonephritis, meeting the drug registration requirements" datetime: "2025-04-15T10:17:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/236023083.md) - [en](https://longbridge.com/en/news/236023083.md) - [zh-HK](https://longbridge.com/zh-HK/news/236023083.md) generator: "portal-rs" --- # Zhongheng Group's wholly-owned subsidiary has received the approval notice for drug clinical trials According to the announcement from Zhongheng Group (600252.SH), on April 14, 2025, the company's wholly-owned subsidiary Guangxi Zhongheng Innovative Pharmaceutical Research Co., Ltd. (referred to as "Zhongheng Innovation") received the Clinical Trial Approval Notice for Sanqi Granules (Specification: 5g per bag) issued by the National Medical Products Administration. According to the Drug Administration Law of the People's Republic of China and relevant regulations, after review, the Sanqi Granules accepted on January 14, 2025, meet the relevant requirements for drug registration, and approval is granted to sequentially conduct Phase II and III clinical trials for chronic glomerulonephritis ### Related Stocks - [600252.CN](https://longbridge.com/en/quote/600252.CN.md) ## Related News & Research - [Constellation’s Volaris buys Brazil cloud communications firm L5 Networks](https://longbridge.com/en/news/296784668.md) - [ENGINEAI says general-purpose humanoid robot costs have fallen below RMB100,000](https://longbridge.com/en/news/296741129.md) - [China's Dongshan Precision to Lift Investment in Unit's Optical Chips, Modules Projects by USD500 Million](https://longbridge.com/en/news/296750539.md) - [China's Growing Pet Market Lures New Entrants From Home Appliance, NEV, Other Industries](https://longbridge.com/en/news/296760049.md) - [03:20 ETMacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology](https://longbridge.com/en/news/296749870.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**